ReWalk reduces IPO target
This article was originally published in Clinica
Israeli robotic exoskeleton developer ReWalk Robotics has set terms for its initial public offering, reducing its target slightly. The company hopes to sell 3.4 million shares at $14-16 apiece, giving it a total of $47.6-54.4m – less than the $57.5m it was initially aiming for. ReWalk plans to float on the Nasdaq under the ticker symbol RWLK.